antibody_basics_9

Learn how antibody optimization techniques like humanization, deimmunization, affinity maturation & Fc engineering improve therapeutic antibodies.

Explore ethical questions around antibody production in animals, the 3Rs principle, and how recombinant technology reduces animal use while ensuring high-quality science.

Explore how monoclonal antibodies combat COVID-19 by neutralizing SARS-CoV-2, including therapies like Actemra, challenges from emerging variants and Biointron’s antibody research.

Learn how antibodies enable protein–protein interaction research using immunofluorescence, immunoprecipitation and co-immunoprecipitation to study signaling pathways and complexes.

Stability makes or breaks biologics. Understand drivers of aggregation, fragmentation, and chemical change—and the formulation tactics that protect quality.

Learn the differences between polyclonal and monoclonal antibodies, including production methods, advantages, limitations, and research or therapeutic applications.

Antibody‑drug conjugates unite precise targeting with potent payloads. Explore linkers, payload classes, DAR control, and the levers that improve efficacy and safety.

Discover advancements in antibody engineering, from bispecific formats to Fc optimization and humanization, driving innovation in next-generation therapeutic antibody development.

Why antibodies transformed immunotherapy: ADCC and CDC, checkpoint blockade, and T‑cell engagement, plus where combinations are headed against resistant tumors.

How ELISA kits achieve specific, reliable readouts: key components, curve fitting, common pitfalls, and QC practices that keep results trustworthy across studies.

Explore the top 10 FDA-approved antibody drugs in 2023, including Humira, Keytruda, and Rituxan, and learn how Biointron supports antibody drug discovery and development.

Learn how antibody screening works, including key methods like ELISA and flow cytometry, and why it is essential for developing drugs, vaccines, and diagnostic applications.

VHH combine small size with big performance—excellent stability, deep tissue access, and easy formatting—making them powerful tools for research and therapy.

Recombinant antibodies deliver speed, consistency, and custom design. Learn how they are engineered, validated, and scaled to out‑perform traditional hybridoma tools.

What an antibody is and why it matters: structure, function, and the roles antibodies play across diagnostics and therapy, explained for fast, confident understanding.